Clinical Trial Update: A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer [NA]

View source ↗

Summary

This document describes a prospective clinical-biological cohort study of patients with BRAFV600E-mutated metastatic colorectal cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Colorectal Cancer, BRAF V600E Mutation Positive | NA | Status: RECRUITING